502 related articles for article (PubMed ID: 17126822)
1. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
2. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
3. Targeting intermediary metabolism in the hypothalamus as a mechanism to regulate appetite.
Lopaschuk GD; Ussher JR; Jaswal JS
Pharmacol Rev; 2010 Jun; 62(2):237-64. PubMed ID: 20392806
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
5. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
6. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
7. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
8. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
9. Expression of genes regulating malonyl-CoA in human skeletal muscle.
Pender C; Trentadue AR; Pories WJ; Dohm GL; Houmard JA; Youngren JF
J Cell Biochem; 2006 Oct; 99(3):860-7. PubMed ID: 16721829
[TBL] [Abstract][Full Text] [Related]
10. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
[TBL] [Abstract][Full Text] [Related]
11. Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure.
Lane MD; Hu Z; Cha SH; Dai Y; Wolfgang M; Sidhaye A
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1063-7. PubMed ID: 16246046
[TBL] [Abstract][Full Text] [Related]
12. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
Ussher JR; Lopaschuk GD
Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
[TBL] [Abstract][Full Text] [Related]
13. Role of lipids in the control of food intake.
Fantino M
Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):138-44. PubMed ID: 21252653
[TBL] [Abstract][Full Text] [Related]
14. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
15. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats.
Atkinson LL; Kozak R; Kelly SE; Onay Besikci A; Russell JC; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E923-30. PubMed ID: 12464581
[TBL] [Abstract][Full Text] [Related]
16. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment.
Steinberg GR; Rush JW; Dyck DJ
Am J Physiol Endocrinol Metab; 2003 Mar; 284(3):E648-54. PubMed ID: 12441311
[TBL] [Abstract][Full Text] [Related]
17. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats.
Kraegen EW; Saha AK; Preston E; Wilks D; Hoy AJ; Cooney GJ; Ruderman NB
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E471-9. PubMed ID: 16234268
[TBL] [Abstract][Full Text] [Related]
18. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
19. Malonyl-CoA decarboxylase is not a substrate of AMP-activated protein kinase in rat fast-twitch skeletal muscle or an islet cell line.
Habinowski SA; Hirshman M; Sakamoto K; Kemp BE; Gould SJ; Goodyear LJ; Witters LA
Arch Biochem Biophys; 2001 Dec; 396(1):71-9. PubMed ID: 11716464
[TBL] [Abstract][Full Text] [Related]
20. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels.
Hall JL; Lopaschuk GD; Barr A; Bringas J; Pizzurro RD; Stanley WC
Cardiovasc Res; 1996 Nov; 32(5):879-85. PubMed ID: 8944819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
